Related references
Note: Only part of the references are listed.Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
J. Chuck Harrell et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells
Yuan Xue et al.
NATURE MEDICINE (2012)
Erythropoietin Induces Lymph Node Lymphangiogenesis and Lymph Node Tumor Metastasis
Ae Sin Lee et al.
CANCER RESEARCH (2011)
Recombinant Human Erythropoietin in Combination with Chemotherapy Increases Breast Cancer Metastasis in Preclinical Mouse Models
Benjamin D. Hedley et al.
CLINICAL CANCER RESEARCH (2011)
Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells
Tania V. Lopez et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Recombinant Human Erythropoietin Antagonizes Trastuzumab Treatment of Breast Cancer Cells via Jak2-Mediated Src Activation and PTEN Inactivation
Ke Liang et al.
CANCER CELL (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Zhizhong Li et al.
CANCER CELL (2009)
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
William Y. Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Molecular characterization of human breast tumor vascular cells
Rajendra Bhati et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Developments in the therapeutic use of erythropoiesis stimulating agents
Wolfgang Jelkmann
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera
Gerlinde Werning et al.
CANCER CELL (2008)
Erythropoiesis-stimulating agent use in cancer: Preclinical and clinical perspectives
Murat O. Arcasoy
CLINICAL CANCER RESEARCH (2008)
The erythropoietin receptor in normal and cancer tissues
Wolfgang Jelkmann et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Darbepoetin alfa for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
Robert E. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors
Robert W. Cho et al.
STEM CELLS (2008)
Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis
Tatsuma Okazaki et al.
NEOPLASIA (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
Effects of recombinant erythropoietin on breast cancer-initiating cells
Tiffany M. Phillips et al.
NEOPLASIA (2007)
Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia
Janice L. Gabrilove et al.
CANCER (2007)
Expression and function of erythropoietin receptors in tumors - Implications for the use of erythropoiesis-stimulating agents in cancer patients
Angus M. Sinclair et al.
CANCER (2007)
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
James R. Wright et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Acute postnatal ablation of Hif-2α results in anemia
Michaela Gruber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Counting colonies of clonogenic assays by using densitometric software
Maximilian Niyazi et al.
RADIATION ONCOLOGY (2007)
Failure to prolyl hydroxylate hypoxia-inducible factor α phenocopies VHL inactivation in vivo
William Y. Kim et al.
EMBO JOURNAL (2006)
Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models
KR LaMontagne et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity
ME Hardee et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
ME Hardee et al.
BRITISH JOURNAL OF CANCER (2005)
The anaemia of cancer: Death by a thousand cuts
JL Spivak
NATURE REVIEWS CANCER (2005)
Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial
JH Savonije et al.
EUROPEAN JOURNAL OF CANCER (2005)
Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma
SY Lai et al.
ONCOGENE (2005)
Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy
J Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
FEF-2α regulates murine hematopoietic development in an erythropoietin-dependent manner
M Scortegagna et al.
BLOOD (2005)
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
B Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cell-type-specific responses to chemotherapeutics in breast cancer
MA Troester et al.
CANCER RESEARCH (2004)
The erythropoietin receptor and its expression in tumor cells and other tissues
F Farrell et al.
ONCOLOGIST (2004)
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
M Henke et al.
LANCET (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
